# Polymeric PLGA Nanoparticles Loaded with Acalypha monostachya Leaf Hexane Extract: A Novel Strategy for Antineoplastic Activity

## TL;DR

This study shows that encapsulating a plant extract in PLGA nanoparticles improves its cancer-fighting effectiveness in lab tests.

## Contribution

Encapsulation of Acalypha monostachya leaf extract in PLGA nanoparticles enhances antineoplastic activity and aqueous dispersibility.

## Key findings

- PLGA nanoparticles with 5/50 extract/polymer ratio had 131.4 nm diameter and 92.03% encapsulation efficiency.
- Encapsulated extract showed higher potency with IC50 values of 30 µg/mL (HeLa) and 60 µg/mL (MDA-MB-231).
- Selectivity indices of 3.2 and 1.6 were observed for HaCaT/HeLa and HaCaT/MDA-MB-231, respectively.

## Abstract

Background/Objectives: Acalypha monostachya is used in rural communities in Mexico as a traditional remedy for cancer, and we previously observed cytotoxic activity of its extracts against MDA-MB-231 and HeLa cells. Methods: Because lipophilic plant fractions disperse poorly in water, we encapsulated the hexane leaf extract (LHE) of A. monostachya in poly (lactic-co-glycolic acid) (PLGA) nanoparticles prepared by nanoprecipitation, characterized them physicochemically, and evaluated their in vitro cytotoxicity. Results: The selected extract/polymer ratio (5/50, w/w) produced nanoparticles with a mean diameter of 131.4 ± 0.5 nm and a PDI of 0.122 ± 0.028, with an encapsulation efficiency of 92.03% and a loading of 8.43%. We next evaluated cytotoxicity by MTT after 24 h in HeLa and MDA-MB-231 cells and compared the response with non-tumorigenic HaCaT keratinocytes. Encapsulation increased potency relative to free LHE, yielding IC50 values of 30 µg/mL (HeLa), 60 µg/mL (MDA-MB-231), and 95 µg/mL (HaCaT). These values corresponded to selectivity indices of 3.2 (HaCaT/HeLa) and 1.6 (HaCaT/MDA-MB-231). Conclusions: Overall, encapsulation of LHE in PLGA nanoparticles yields an aqueous PLGA nanoparticle suspension and is associated with improved in vitro potency while maintaining measurable selectivity against cancer cells.